You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

disease flare

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Synovial Tissue and Blood Signature of Rheumatoid Arthritis

Active, not recruiting
  • Rheumatoid Arthritis
  • Evaluation of subclinical inflammation
  • Brescia, Lombardia, Italy
  • +2 more
Mar 2, 2023

Gout, Chronic Kidney Disease, Renal Transplantation Trial in Paris (Anakinra 100Mg/0.67Ml Inj Syringe, Prednisone, Placebo of

Recruiting
  • Gout
  • +2 more
  • Anakinra 100Mg/0.67Ml Inj Syringe
  • +3 more
  • Paris, Ile-De-France, France
    Rhumathology department
Aug 22, 2022

Ulcerative Colitis Trial in Chicago (Alicaforsen)

Completed
  • Ulcerative Colitis
  • Chicago, Illinois
    (unnamed)
Dec 1, 2022

Crohn's Disease, Inflammatory Bowel Disease Trial in New Haven (Corticosteroid)

Terminated
Has Results
  • Crohn's Disease
  • Inflammatory Bowel Disease
  • New Haven, Connecticut
    Yale-New Haven Hospital
Aug 5, 2021

Myoelectric GutPrint-Crohn's Disease

Recruiting
  • Crohn Disease
  • G-Tech Gutcheck Myoelectric recording device
  • Palo Alto, California
    Stanford University
Apr 21, 2022

Generalized Pustular Psoriasis Trial in China (spesolimab)

Recruiting
  • Generalized Pustular Psoriasis
  • Beijing, China
  • +10 more
Jan 23, 2023

Age-related Cataract Trial in Tours (Ocular Surface Disease Index, Interferometry, Oxford score)

Not yet recruiting
  • Age-related Cataract
  • Ocular Surface Disease Index
  • +5 more
  • Tours, France
    KHANNA
Apr 6, 2023

COPD Trial in Liverpool (Senti Wear device system with Senti-AI subsystem)

Not yet recruiting
  • COPD
  • Senti Wear device system with Senti-AI subsystem
  • Liverpool, Merseyside, United Kingdom
    Senti Tech
Feb 15, 2023

Rheumatoid Arthritis Trial (Discontinuation of biological/targeted synthetic disease modifying anti-rheumatic drug (b/tsDMARD))

Not yet recruiting
  • Rheumatoid Arthritis
  • Discontinuation of biological/targeted synthetic disease modifying anti-rheumatic drug (b/tsDMARD)
  • (no location specified)
Nov 12, 2021

TAAI Erasmus Research Initiative to Fight CF: Monitoring

Recruiting
  • Cystic Fibrosis
  • +9 more
    • Rotterdam, Zuid-Holland, Netherlands
      Erasmus MC - Sophia Children's Hospital
    Feb 21, 2023

    Dry Eye Disease Trial in United States (0.02% Betamethasone Sodium Phosphate, 0.04% Betamethasone Sodium Phosphate, Placebo)

    Completed
    • Dry Eye Disease
    • 0.02% Betamethasone Sodium Phosphate
    • +2 more
    • Dothan, Alabama
    • +27 more
    Nov 9, 2022

    Prediction of 30-Day Readmission Using Machine Learning

    Not yet recruiting
    • Infection
    • +8 more
      • Boston, Massachusetts
      • +1 more
      Feb 3, 2022

      Generalized Pustular Psoriasis Trial in Worldwide (Spesolimab, Placebo)

      Completed
      Has Results
      • Generalized Pustular Psoriasis
      • Birmingham, Alabama
      • +36 more
      Feb 11, 2022

      Prediction of Patient Deterioration Using Machine Learning

      Active, not recruiting
      • Infection
      • +8 more
      • Traditional vital sign alarms versus the BioVitals Index vs the National Early Warning Score 2
      • Boston, Massachusetts
      • +1 more
      Sep 15, 2021

      Infection, Heart Failure, COPD Trial in Salt Lake City (Home hospital care)

      Completed
      • Infection
      • +8 more
      • Home hospital care
      • Salt Lake City, Utah
        University of Utah Health
      Jul 6, 2021

      Expected Length of Hospital Stay Using Machine Learning

      Active, not recruiting
      • Infection
      • +8 more
        • Boston, Massachusetts
        • +1 more
        Apr 14, 2021

        Dissecting Cellular and Molecular Atlas of Rheumatoid Arthritis

        Recruiting
        • Rheumatoid Arthritis
        • Tapering and/or discontinuation of treatment based on AI-guidance
        • +3 more
        • Rome, Italy
        • +3 more
        Jul 20, 2023

        IgG4 Related Disease Trial in Worldwide (Inebilizumab, Placebo)

        Recruiting
        • IgG4 Related Disease
        • Palo Alto, California
        • +81 more
        Oct 19, 2022

        Infection, Heart Failure, COPD Trial in Boston (Remote Visit)

        Completed
        • Infection
        • +8 more
        • Remote Visit
        • Boston, Massachusetts
        • +1 more
        Nov 26, 2020

        Giant Cell Arteritis Trial in Brest, Lille, Mulhouse (Tocilizumab)

        Completed
        • Giant Cell Arteritis
        • Brest, France
        • +2 more
        Sep 2, 2020

        Disease Course In Ulcerative Colitis Using Multimodal Machine

        Recruiting
        • Ulcerative Colitis
        • Deep learning model
        • Hvidovre, Denmark
          Gastrounit, medical section, Copenhagen University Hospital Hvid
        Jul 26, 2022

        IgG4 Related Disease Trial in United States (Obexelimab, Placebo)

        Recruiting
        • IgG4 Related Disease
        • Walnut Creek, California
        • +3 more
        Jan 27, 2023

        Air Pollution on SPondyloarthritis Flare-ups and Resistance to

        Not yet recruiting
        • Spondyloarthritis, Axial
        • Assessment of exposure to air pollution
        • Besançon, Bourgogne Franche Comté, France
          Besançon University Hospital
        Oct 5, 2023

        Adalimumab Withdrawal or Continuation on Severity of COVID-19

        Completed
        • Inflammatory Bowel Diseases
        • Rheumatic Disorder
        • Milano, Italy
          Irccs Ospedale San Raffaele
        Jan 30, 2023

        Rheumatoid Intentional Therapy Tapering

        Not yet recruiting
        • Rheumatoid Arthritis
        • 99mMaracticaltide imaging
        • (no location specified)
        Aug 2, 2023